Vidac Pharma Holding Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • T9G

Stock Symbol

  • Share Price
  • $0.21
  • (As of Friday Closing)

Vidac Pharma Holding General Information

Description

Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company that focuses on discovering and developing medicines for oncologic and onco-dermatologic diseases. The company's research targets the modification of the tumor microenvironment to inhibit cancer cell growth by selectively affecting metabolic checkpoints in cancer cells without harming normal tissue. Its drug pipeline includes candidates such as VDA-1102 ointment, VDA-1102 IV, and VDA-1275, which are designed to treat conditions like Actinic Keratosis and Cutaneous T-cell Lymphoma.

Contact Information

Formerly Known As
Vidac Pharma Holding Limited
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 20-22 Wenlock Road
  • London N1 7GU
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
STU
Vertical(s)
Corporate Office
  • 20-22 Wenlock Road
  • London N1 7GU
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidac Pharma Holding Stock Performance

As of 13-Nov-2026, Vidac Pharma Holding’s stock price is $0.21. Its current market cap is $12.2M with 56.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.21 $0.21 $0.15 - $1.12 $12.2M 56.9M 7.76K

Vidac Pharma Holding Financials Summary

As of 30-Jun-2026, Vidac Pharma Holding has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 30,772 38,361 38,221
Revenue 0 0 0 0
EBITDA (3,164) (2,533) (1,685) (1,596)
Net Income (3,164) (2,490) (1,771) (1,585)
Total Assets 335 883 2,964 152
Total Debt 452 424 402 181
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vidac Pharma Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vidac Pharma Holding‘s full profile, request access.

Request a free trial

Vidac Pharma Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company that focuses on discovering and developing medici
Drug Discovery
London, United Kingdom
7 As of 2025

Foster City, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vidac Pharma Holding Competitors (18)

One of Vidac Pharma Holding’s 18 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gilead Formerly VC-backed Foster City, CA
Avalyn Pharma Formerly VC-backed Boston, MA
Amgen Formerly PE-Backed Thousand Oaks, CA
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 18 competitors. Get the full list »

Vidac Pharma Holding Patents

Vidac Pharma Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190777-A1 Formulations for delivery of hydrophobic drugs or drugs sensitive to rapid hydrolysis and uses thereof Pending 09-Mar-2025
AU-2025215741-A1 Synergistic therapies for treating cancer Pending 30-Jan-2024
WO-2025163633-A1 Synergistic therapies for treating cancer Pending 30-Jan-2024
EP-3735402-A1 Methods for preparation of jasmonate compounds Inactive 07-Jan-2018
EP-3735402-A4 Methods for preparation of jasmonate compounds Inactive 07-Jan-2018 C07D215/32
To view Vidac Pharma Holding’s complete patent history, request access »

Vidac Pharma Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vidac Pharma Holding ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Vidac Pharma Holding’s complete esg history, request access »

Vidac Pharma Holding FAQs

  • When was Vidac Pharma Holding founded?

    Vidac Pharma Holding was founded in 2012.

  • Where is Vidac Pharma Holding headquartered?

    Vidac Pharma Holding is headquartered in London, United Kingdom.

  • What is the size of Vidac Pharma Holding?

    Vidac Pharma Holding has 7 total employees.

  • What industry is Vidac Pharma Holding in?

    Vidac Pharma Holding’s primary industry is Drug Discovery.

  • Is Vidac Pharma Holding a private or public company?

    Vidac Pharma Holding is a Public company.

  • What is Vidac Pharma Holding’s stock symbol?

    The ticker symbol for Vidac Pharma Holding is T9G.

  • What is the current stock price of Vidac Pharma Holding?

    As of 13-Nov-2026 the stock price of Vidac Pharma Holding is $0.21.

  • What is the current market cap of Vidac Pharma Holding?

    The current market capitalization of Vidac Pharma Holding is $12.2M.

  • Who are Vidac Pharma Holding’s competitors?

    Gilead, Avalyn Pharma, Amgen, Ona Therapeutics, and Merck & Co. are some of the 18 competitors of Vidac Pharma Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process